Senofilcon A [clinicaltrials_resource:NCT00762502/group/E1]
senofilcon A lenses (test) worn daily bilaterally (in both eyes) for 6 months, replaced weekly OR senofilcon A toric lenses worn contralaterally for 6 months, replaced weekly. All enrolled subjects are included. Subjects are counted by device, there are some subjects that are counted in both arms that are from the contralateral group, as identified in the participant flow.
Reported events for NCT00762502 [clinicaltrials_resource:388a6243cd2054d5a3ebb6f5c40983c7]Total, other adverse events for NCT00762502 for E1 in NCT00762502 [clinicaltrials_resource:NCT00762502/other_events/3/count/5]Non-Significant Events for NCT00762502 for E1 in NCT00762502 [clinicaltrials_resource:NCT00762502/other_events/4/count/7]Total, serious adverse events for NCT00762502 for E1 in NCT00762502 [clinicaltrials_resource:NCT00762502/serious_events/1/count/1]Microbial Karatitis for NCT00762502 for E1 in NCT00762502 [clinicaltrials_resource:NCT00762502/serious_events/2/count/3]
group [clinicaltrials_vocabulary:group]
Senofilcon A [clinicaltrials_resource:NCT00762502/group/E1]
senofilcon A lenses (test) worn daily bilaterally (in both eyes) for 6 months, replaced weekly OR senofilcon A toric lenses worn contralaterally for 6 months, replaced weekly. All enrolled subjects are included. Subjects are counted by device, there are some subjects that are counted in both arms that are from the contralateral group, as identified in the participant flow.
Bio2RDF identifier
NCT00762502/group/E1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00762502/group/E1
group id [clinicaltrials_vocabulary:group-id]
description
senofilcon A lenses (test) wor ...... ified in the participant flow.
@en
identifier
clinicaltrials_resource:NCT00762502/group/E1
title
Senofilcon A
@en
type
label
Senofilcon A [clinicaltrials_resource:NCT00762502/group/E1]
@en